| 产品名称: | 3G3 |
|---|---|
| 商品货号: | TS212886 |
| Organism: | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type: | hybridoma: B lymphocyte |
| Product Format: | frozen |
| Morphology: | lymphoblast |
| Culture Properties: | suspension |
| Biosafety Level: | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Applications: | The antibody reacts with cell wall peptidoglycans from a variety of gram- and gram+ organisms. |
| Disclosure: | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation: | Spleen cells were fused with Sp2/0-Ag14 myeloma cells. |
| Genes Expressed: | immunoglobulin; monoclonal antibody; against bacterial cell wall peptidoglycan |
| Cellular Products: | immunoglobulin; monoclonal antibody; against bacterial cell wall peptidoglycan |
| Tumorigenic: | Yes |
| Effects: | Yes, forms ascites in pristane primed BALB/cJ mice |
| Comments: | Animals were immunized with Streptococcus mutans (BHT strain) bacterial cell wall peptidoglycan. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. The antibody reacts with cell wall peptidoglycans from a variety of gram- and gram+ organisms. |
| Complete Growth Medium: | CULTURE MEDIUM: Dulbeccos modified Eagles medium with 4.5 g/L glucose, 90%; fetal bovine serum, 10%. |
| Subculturing: | Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Isotype: | IgM; lambda light chain |
| Name of Depositor: | Temple University |
| Deposited As: | mouse (B cell); mouse (myeloma) |
| U.S. Patent Number: | |
| References: | Jackson DE, et al. Monoclonal antibodies to peptidoglycan and methods of preparing same. US Patent 4,596,769 dated Jun 24 1986 |